| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 04/11/2013 | US20130089613 Compounds Having Activating Effect on Subtypes of Peroxisome Proliferator-Activated Receptors and its Preparation Method and Uses |
| 04/10/2013 | EP2576520A1 Radiolabeled compounds and methods thereof |
| 04/10/2013 | EP2576500A2 Process for producing aliskiren |
| 04/10/2013 | CN103038223A Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents |
| 04/09/2013 | US8415359 Phenylpyrrole derivative |
| 04/04/2013 | WO2013046781A1 Intermediate for manufacture of polymerizable compound and process for manufacture thereof |
| 04/04/2013 | WO2013014204A3 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 04/04/2013 | US20130085276 Carboxylation catalysts |
| 04/04/2013 | US20130085147 Hepatitis C Virus Inhibitors |
| 04/03/2013 | CN103025716A Bicyclic compound derivatives and their use as acc inhibitors |
| 04/03/2013 | CN103012314A Sulfonamide compound and preparation method as well as application thereof |
| 04/03/2013 | CN103012304A Compounds for preparing immunological adjuvant |
| 04/03/2013 | CN103012169A Compounds for preparing immunological adjuvant |
| 04/03/2013 | CN102241641B Synthesis method of 2-trifluoromethyloxazole derivatives |
| 04/03/2013 | CN102219755B Micromolecule selective depressant for STAT3 (Signal transducer and activator of transcription 3), as well as preparation method and applications thereof |
| 04/02/2013 | US8410150 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 03/28/2013 | WO2012166463A3 Aminooxazole inhibitors of cyclin dependent kinases |
| 03/28/2013 | US20130079374 Tricyclic compound and pharmaceutical use thereof |
| 03/28/2013 | US20130079339 Trpv1 vanilloid receptor antagonists with a bicyclic portion |
| 03/28/2013 | US20130079271 Reversed biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 03/27/2013 | CN1964956B Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 03/27/2013 | CN102994073A Benzoxazole-based fluorescent-identified RAFT reagent, synthesis method and application |
| 03/27/2013 | CN102993084A Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/27/2013 | CN102153555B Carbapenem compound containing amido formacyl heterocycle |
| 03/27/2013 | CN101616902B 2-aminooxazolines as TAAR1 ligands |
| 03/26/2013 | US8404728 Small-molecule botulinum toxin inhibitors |
| 03/26/2013 | US8404722 Oxazole compounds compositions and methods of use |
| 03/21/2013 | WO2013039140A1 Fused heterocyclic derivative |
| 03/21/2013 | WO2013038351A1 Solid forms of a transthyretin dissociation inhibitor |
| 03/21/2013 | WO2013038136A1 BI-AROMATIC AND TRI-AROMATIC COMPOUNDS AS NADPH OXIDASE 2 (Nox2) INHIBITORS |
| 03/21/2013 | US20130071899 Process for Producing Aliskiren |
| 03/21/2013 | CA2847293A1 Solid forms of a transthyretin dissociation inhibitor |
| 03/20/2013 | EP2569291A1 Selective glycosidase inhibitors and uses thereof |
| 03/20/2013 | CN102985410A Combretastatin analogs for use in the treatment of cancer |
| 03/20/2013 | CN102978253A Method for synthesising ezetimibe intermediate |
| 03/20/2013 | CN102977045A 4-(5-amino-6-hydroxybenzoxazole-2-yl)ammonium benzoate as well as preparation method and application thereof |
| 03/20/2013 | CN102977032A Heterocyclic bridged biphenyls and their use in OLEDs |
| 03/19/2013 | US8399675 Compounds and preparation for montelukast sodium |
| 03/19/2013 | CA2706872C Intermediates for the preparation of lipoxin a4 analogs |
| 03/19/2013 | CA2319465C Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 03/14/2013 | WO2013013113A3 Histone deacetylase 6 selective inhibitors for the treatment of bone disease |
| 03/14/2013 | WO2011128388A3 Oxazole and thiazole compounds as ksp inhibitors |
| 03/14/2013 | US20130066076 Process for the Synthesis of Biaryl Oxazolidinones |
| 03/13/2013 | EP2566854A2 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents |
| 03/13/2013 | EP2566851A1 Combretastatin analogs for use in the treatment of cancer |
| 03/13/2013 | CN102964311A Method for synthesizing 4-methyl-5-alkoxyl oxazole |
| 03/13/2013 | CN102964310A Preparation method of 2-position substituted imidazole |
| 03/13/2013 | CN102050720B Novel DHA derivative and its usage as medicine |
| 03/13/2013 | CN101213281B 新的dha衍生物及其作为药物的用途 Dha new derivatives and their use as medicament |
| 03/12/2013 | US8394841 Compounds and methods for modulating G protein-coupled receptors |
| 03/12/2013 | US8394799 Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component |
| 03/12/2013 | US8394794 Therapeutic compounds |
| 03/12/2013 | US8394787 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof |
| 03/12/2013 | CA2706661C Intermediates for the preparation of lipoxin a4 analogs |
| 03/12/2013 | CA2603826C Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 03/12/2013 | CA2558051C Palladium catalyzed indolization of 2-bromo or chloroanilines |
| 03/12/2013 | CA2510455C Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 03/12/2013 | CA2388505C 5-membered heterocycle derivatives, their preparation and application as medicine |
| 03/07/2013 | WO2013033245A1 Bicyclic methylene aziridines and reactions thereof |
| 03/07/2013 | US20130058990 Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent |
| 03/06/2013 | EP2565184A1 Therapeutic agent and preventative agent for alzheimer's disease |
| 03/06/2013 | EP2563781A1 Processes for preparing linezolid |
| 03/06/2013 | EP2563765A1 Bicyclic compound derivatives and their use as acc inhibitors. |
| 03/06/2013 | CN102958906A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/06/2013 | CN102952092A Oxazolidine ionic liquid and preparation method and application thereof |
| 03/06/2013 | CN101142175B Peptidic compounds |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389570 Hydroxamates as therapeutic agents |
| 02/28/2013 | WO2013027694A1 Molecular imaging probes for diagnosing conformation disease |
| 02/28/2013 | US20130053416 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053412 Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use |
| 02/28/2013 | US20130053387 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents |
| 02/28/2013 | US20130053364 Sulphone Compounds and Methods of Making and Using Same |
| 02/27/2013 | EP2562160A1 Therapeutic agent or preventive agent for urine collection disorder |
| 02/27/2013 | EP2562157A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
| 02/27/2013 | CN102947281A Novel aminoalkyl-oxazole and aminoalkyl-thiazole carboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue |
| 02/27/2013 | CN102947280A Carboxy oxazole or thiazole compounds as dgat - 1 inhibitors useful for the treatment of obesity |
| 02/27/2013 | CN102942533A Preparation method of 4-(5-amino-6-hydroxy-2-benzoxazolyl) benzoic acid (ABA) |
| 02/26/2013 | US8383622 Nitrogen-containing heterocyclic derivative having 11β-hydroxysteroid dehydrogenase type I inhibitory activity |
| 02/21/2013 | WO2013025733A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | CA2844982A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
| 02/20/2013 | EP2558452A2 Oxazole and thiazole compounds as ksp inhibitors |
| 02/20/2013 | CN102936228A Method for preparing 6-(2-fluoroethoxy)-2-methylbenzoxazole |
| 02/19/2013 | US8378120 Method and reagent for measuring nitroreductase enzyme activity |
| 02/19/2013 | US8378095 Oxazole tyrosine kinase inhibitors |
| 02/19/2013 | US8377942 Isoxazolines derivatives and their use as pesticide |
| 02/14/2013 | WO2013022047A1 Cyclopropaneamine compound |
| 02/14/2013 | US20130041158 Therapeutic agent and preventative agent for alzheimer's disease |
| 02/14/2013 | US20130041157 Therapeutic agent or preventive agent for urine collection disorder |
| 02/14/2013 | CA2844525A1 Cyclopropaneamine compound |
| 02/13/2013 | EP2555772A1 Oxazole derivatives useful as modulators of faah |
| 02/13/2013 | CN102924367A Benzanthracene organic light-emitting material and preparation method thereof |
| 02/13/2013 | CN101952260B 4, 5-dihydro-oxazol-2-yl amine derivatives |
| 02/13/2013 | CN101293874B Polyalcohol-filling material coupling additive agent |
| 02/12/2013 | US8372984 Dual-acting oxazole antihypertensive agents |
| 02/12/2013 | US8372982 Fungicidal N-(Phenylcycloalkyl)carboxamide, N-(Benzylcycloalkyl)carboxamide and thiocarboxamide derivatives |
| 02/07/2013 | WO2012073041A3 Inhibitors of apurinic/apyrimidinic endonuclease 1 (ape1) and their use |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |